CA2462747A1 - Breast cancer prognostics - Google Patents

Breast cancer prognostics Download PDF

Info

Publication number
CA2462747A1
CA2462747A1 CA002462747A CA2462747A CA2462747A1 CA 2462747 A1 CA2462747 A1 CA 2462747A1 CA 002462747 A CA002462747 A CA 002462747A CA 2462747 A CA2462747 A CA 2462747A CA 2462747 A1 CA2462747 A1 CA 2462747A1
Authority
CA
Canada
Prior art keywords
genes
set forth
txt
cds
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002462747A
Other languages
English (en)
French (fr)
Inventor
Yixin Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Diagnostics LLC
Original Assignee
Janssen Diagnostics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Diagnostics LLC filed Critical Janssen Diagnostics LLC
Publication of CA2462747A1 publication Critical patent/CA2462747A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA002462747A 2003-04-24 2004-04-23 Breast cancer prognostics Abandoned CA2462747A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/422,522 2003-04-24
US10/422,522 US7306910B2 (en) 2003-04-24 2003-04-24 Breast cancer prognostics

Publications (1)

Publication Number Publication Date
CA2462747A1 true CA2462747A1 (en) 2004-10-24

Family

ID=32962443

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002462747A Abandoned CA2462747A1 (en) 2003-04-24 2004-04-23 Breast cancer prognostics

Country Status (10)

Country Link
US (2) US7306910B2 (es)
EP (1) EP1471154A3 (es)
JP (1) JP2004344171A (es)
KR (1) KR20040096423A (es)
CN (1) CN1715421A (es)
AR (1) AR044099A1 (es)
AU (2) AU2004201706A1 (es)
BR (1) BRPI0403290A (es)
CA (1) CA2462747A1 (es)
MX (1) MXPA04003931A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
KR100763902B1 (ko) * 2004-02-20 2007-10-05 삼성전자주식회사 유방암 특이적 단백질, 그를 코딩하는 유전자, 및 상기단백질 또는 유전자를 이용한 유방암의 진단 방법
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2006108135A2 (en) * 2005-04-04 2006-10-12 Veridex, Llc Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways
EP2380978A3 (en) * 2006-02-03 2012-02-29 MessengerScape Co. Ltd. Gene group applicable to cancer prognostication
WO2008094678A2 (en) * 2007-01-31 2008-08-07 Applera Corporation A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
CA2682868A1 (en) * 2007-04-05 2008-10-16 Source Precision Medicine, Inc. D/B/A Source Mdx Gene expression profiling for identification, monitoring, and treatment of breast cancer
CN102016881B (zh) * 2008-04-25 2013-06-12 皇家飞利浦电子股份有限公司 样本数据的分类
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US8597885B2 (en) * 2009-01-28 2013-12-03 University Of Notre Dame Accelerated progression relapse test
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
WO2011122857A2 (ko) * 2010-03-30 2011-10-06 서울대학교 산학협력단 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
AU2013248989A1 (en) * 2012-04-20 2014-11-27 Memorial Sloan-Kettering Cancer Center Gene expression profiles associated with metastatic breast cancer
GB201510684D0 (en) * 2015-06-17 2015-08-05 Almac Diagnostics Ltd Gene signatures predictive of metastatic disease
CN110172461B (zh) * 2019-06-03 2023-05-09 上海长征医院 一种新型骨肉瘤肺转移模型的构建方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500010A (ja) 1997-12-23 2002-01-08 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ｉ
WO2002010436A2 (en) 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Prognostic classification of breast cancer
WO2002068579A2 (en) 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
AU2002253878A1 (en) 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
ATE503023T1 (de) * 2001-06-18 2011-04-15 Rosetta Inpharmatics Llc Diagnose und prognose von brustkrebspatientinnen
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
JP2006519620A (ja) 2003-03-04 2006-08-31 アークチュラス バイオサイエンス，インコーポレイティド 乳がんにおけるｅｒ状態の弁別特性

Also Published As

Publication number Publication date
MXPA04003931A (es) 2004-11-29
CN1715421A (zh) 2006-01-04
AU2004201706A1 (en) 2004-11-11
US20040214179A1 (en) 2004-10-28
EP1471154A3 (en) 2005-02-09
US8183353B2 (en) 2012-05-22
BRPI0403290A (pt) 2005-07-12
JP2004344171A (ja) 2004-12-09
AU2004201761A1 (en) 2004-11-11
KR20040096423A (ko) 2004-11-16
EP1471154A2 (en) 2004-10-27
US7306910B2 (en) 2007-12-11
US20100009861A1 (en) 2010-01-14
AR044099A1 (es) 2005-08-24

Similar Documents

Publication Publication Date Title
CA2462747A1 (en) Breast cancer prognostics
US6582919B2 (en) Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
CA2436910C (en) Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates
CA2395781C (en) Detection and treatment of polycystic kidney disease
AU2008286361B2 (en) IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease
CA2852855A1 (en) Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
US20150025230A1 (en) Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
CA2651376A1 (en) Method for diagnosis and treatment of a mental disease
AU2008203226A1 (en) Colorectal cancer prognostics
EP1756317A2 (en) Methods for identifying risk of osteoarthritis and treatments thereof
EP3102697A1 (en) Method for predicting the response to an anti-her2 containing therapy and/or chemotherapy in patients with breast cancer
KR20130123357A (ko) 저산소증과 관련된 질환의 진단방법 및 키트
WO2014138396A1 (en) Methods of detecting bladder cancer
CN1637151B (zh) 结肠直肠癌预后
KR20100037637A (ko) Ｅｇｆｒ 억제제 치료에 대한 예측 마커
Robetorye et al. Microarray analysis of B-cell lymphoma cell lines with the t (14; 18)
US6475739B2 (en) Methods for identifying genomic deletions
CA2587863A1 (en) Genes associated with colorectal cancer
AU2013276994C1 (en) IVIG Modulations of Chemokines for Treatment of Multiple Sclerosis, Alzheimer's Disease, and Parkinson's Disease
US20040265804A1 (en) Method for identifying metastatic tumor cells
CN113789378A (zh) Hoxa5的fish检测探针及其试剂盒和应用
US20020115085A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
JP2000287684A (ja) 癌及び流産に関与する染色体領域９ｐ１１の塩基配列
MXPA04008401A (es) Diagnostico de cáncer colorrectal

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued